BACKGROUND: Recent work has demonstrated a link between retinopathy, a marker of microvascular disease, and the development of heart failure, a finding particularly relevant in individuals with diabetes. Our objective was to assess the relationship between retinopathy and cardiac structure and function in a cohort of individuals with type 2 diabetes mellitus. METHODS: Stereoscopic fundus photography of 7 standard fields was obtained in 531 Mexican American adults with type 2 diabetes mellitus recruited as sibships from Starr County, Texas. Retinopathy was centrally scored and classified as no retinopathy, early nonproliferative diabetic retinopathy, moderate to severe nonproliferative diabetic retinopathy, or proliferative diabetic retinopathy. Echocardiography was used to assess cardiac structure and function. Multilevel mixed models were used to assess associations of clinical and echocardiographic variables with retinopathy while accounting for correlations among siblings. RESULTS: More severe diabetic retinopathy was associated with the presence of hypertension, previous cardiovascular disease, longer duration of diabetes, elevated glycosylated hemoglobin, and greater albuminuria. With worsening severity of diabetic retinopathy, left ventricular (LV) mass and left atrial dimension increased, and LV ejection fraction and LV fractional shortening decreased, independent of potential confounding variables. CONCLUSIONS: More severe diabetic retinopathy was associated with worse cardiac structure and function by echocardiography independent of potential confounding variables. These data suggest a possible microvascular contribution to the development of diabetes-associated cardiac enlargement and dysfunction. Alternatively, common pathways may be leading to both disorders.
BACKGROUND: Recent work has demonstrated a link between retinopathy, a marker of microvascular disease, and the development of heart failure, a finding particularly relevant in individuals with diabetes. Our objective was to assess the relationship between retinopathy and cardiac structure and function in a cohort of individuals with type 2 diabetes mellitus. METHODS: Stereoscopic fundus photography of 7 standard fields was obtained in 531 Mexican American adults with type 2 diabetes mellitus recruited as sibships from Starr County, Texas. Retinopathy was centrally scored and classified as no retinopathy, early nonproliferative diabetic retinopathy, moderate to severe nonproliferative diabetic retinopathy, or proliferative diabetic retinopathy. Echocardiography was used to assess cardiac structure and function. Multilevel mixed models were used to assess associations of clinical and echocardiographic variables with retinopathy while accounting for correlations among siblings. RESULTS: More severe diabetic retinopathy was associated with the presence of hypertension, previous cardiovascular disease, longer duration of diabetes, elevated glycosylated hemoglobin, and greater albuminuria. With worsening severity of diabetic retinopathy, left ventricular (LV) mass and left atrial dimension increased, and LV ejection fraction and LV fractional shortening decreased, independent of potential confounding variables. CONCLUSIONS: More severe diabetic retinopathy was associated with worse cardiac structure and function by echocardiography independent of potential confounding variables. These data suggest a possible microvascular contribution to the development of diabetes-associated cardiac enlargement and dysfunction. Alternatively, common pathways may be leading to both disorders.
Authors: Sharon A Brown; Heather A Becker; Alexandra A Garcia; Sara A Barton; Craig L Hanis Journal: Res Nurs Health Date: 2002-04 Impact factor: 2.228
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Stuart J Pocock; Duolao Wang; Marc A Pfeffer; Salim Yusuf; John J V McMurray; Karl B Swedberg; Jan Ostergren; Eric L Michelson; Karen S Pieper; Christopher B Granger Journal: Eur Heart J Date: 2005-10-11 Impact factor: 29.983
Authors: V Palmieri; J N Bella; D K Arnett; J E Liu; A Oberman; M Y Schuck; D W Kitzman; P N Hopkins; D Morgan; D C Rao; R B Devereux Journal: Circulation Date: 2001-01-02 Impact factor: 29.690
Authors: R B Devereux; M J Roman; M Paranicas; M J O'Grady; E T Lee; T K Welty; R R Fabsitz; D Robbins; E R Rhoades; B V Howard Journal: Circulation Date: 2000-05-16 Impact factor: 29.690
Authors: Ning Cheung; Jie J Wang; Sophie L Rogers; Frederick Brancati; Ronald Klein; A Richey Sharrett; Tien Y Wong Journal: J Am Coll Cardiol Date: 2008-04-22 Impact factor: 24.094
Authors: Richard B Devereux; Giovanni de Simone; Donna K Arnett; Lyle G Best; Eric Boerwinkle; Barbara V Howard; Dalane Kitzman; Elisa T Lee; Thomas H Mosley; Alan Weder; Mary J Roman Journal: Am J Cardiol Date: 2012-07-06 Impact factor: 2.778
Authors: Natalie A Bello; Marc A Pfeffer; Hicham Skali; Janet B McGill; Jerome Rossert; Kurt A Olson; Larry Weinrauch; Mark E Cooper; Dick de Zeeuw; Peter Rossing; John J V McMurray; Scott D Solomon Journal: BMJ Open Diabetes Res Care Date: 2014-04-06
Authors: Marilia B Gomes; Daniel Giannella-Neto; Manuel Faria; Marcos Tambascia; Reine M Fonseca; Rosangela Rea; Geisa Macedo; João Modesto-Filho; Helena Schmid; Alcina V Bittencourt; Saulo Cavalcanti; Nelson Rassi; Hermelinda Pedrosa; Sergio A Dib Journal: Diabetol Metab Syndr Date: 2009-10-27 Impact factor: 3.320
Authors: Craig L Hanis; Susan Redline; Brian E Cade; Graeme I Bell; Nancy J Cox; Jennifer E Below; Eric L Brown; David Aguilar Journal: Cardiovasc Diabetol Date: 2016-06-08 Impact factor: 9.951